slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,41 EUR | +22,02% | -89,27% | -85,86% |
Vakgebied
De firma beschikt over een product in de klinische ontwikkelingsfase II/III (Glenzocimab).
Aantal werknemers: 29
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Avenard
FOU | Founder | - | 26-11-13 |
Eric Cohen
DFI | Director of Finance/CFO | - | - |
Adeline Meilhoc
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01-11-18 | |
Aymeric Humblot
ADM | Chief Administrative Officer | - | - |
Sophie Binay
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yannick Plétan
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-17 |
James Stearns
PRN | Corporate Officer/Principal | - | - |
Jessica Jami
LAW | General Counsel | - | 01-11-19 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gilles Avenard
FOU | Founder | - | 26-11-13 |
Catherine Boule
BRD | Director/Board Member | - | - |
Alain Munoz
CHM | Chairman | 75 | 15-06-21 |
Alain Parthoens
BRD | Director/Board Member | 64 | 24-10-18 |
Rinaldo del Bono
BRD | Director/Board Member | - | - |
Guy Heynen
BRD | Director/Board Member | - | - |
Patricia Zilliox
BRD | Director/Board Member | - | 26-01-23 |
Corporate Officer/Principal | - | - | |
Leila Nicolas
BRD | Director/Board Member | - | - |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 338 781 | 12 338 781 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Acticor Biotech SAS
Bâtiment Inserm U1148 Hôpital Bichat
75877, Paris
+33 6 76 23 38 13
http://www.acticor-biotech.comSector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-85,86% | 5,77 mln. | |
-2,63% | 102 mld. | |
+1,62% | 96,29 mld. | |
+2,68% | 22,18 mld. | |
-16,67% | 21,2 mld. | |
-8,77% | 18,31 mld. | |
-38,74% | 17,38 mld. | |
-13,21% | 16,36 mld. | |
+5,41% | 13,97 mld. | |
+33,57% | 12,17 mld. |
- Beurs
- Aandelen
- Koers ALACT
- Onderneming Acticor Biotech SAS